
Articles

🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
DOJ Intervenes In Qui Tam Lawsuit Against Mental Health Provider
Urgent Care Provider Agrees to Pay $22.5 Million to Settle Allegations of Billing for Non-Credentialed Services
Citing Campie, Ninth Circuit Partially Reverses Dismissal of FCA Complaint Alleging Underlying Fraud on the FDA; United States Court of Appeals for the Ninth Circuit No. 19-56377, U.S. ex rel. The Dan Abrams Company LLC v. Medtronic Inc., et al.
Defendants’ Alleged Conduct Suggests They Knew Noncompliance was Material; United States District Court for the District of South Carolina, Columbia Division, No. 3:19-cv-03403-JMC, U.S. ex rel. Jeffrey Harbit and Alan Inglett v. Consultants in Gastroenterology P.A., et al.
Successful Qui Tam Defendant Can’t Recover Costs She Didn’t Pay; United States District Court for the Southern District of Mississippi, Southern Division, No. 1:16-CV00369 HTW-LGI, U.S. ex rel. James Aldridge v. Corporate Management Inc., et al.
The Stark Law and Anti-Kickback Statute Final Rules: Value-Based Arrangements
DOJ Updates Actions to Combat Fraud Related to COVID-19
FCA Enforcement Priorities in the Biden Administration
Improper Billing Allegations Cost Behavioral Health Provider $273,000
GSA Bid Rigging Case Nets Another Guilty Plea
Retaliation Against a Former Employee Can Give Rise to a False Claims Act Retaliation Claim
Biden’s New HHS Secretary Promises “Robust Enforcement”
False Claims Act Enforcement in 2021: A Look Ahead
Healthcare Fraud in the Early Days of the Biden Administration
The Powerful False Claims Act You Don’t Know About: California’s Insurance Fraud Prevention Act
Latin America Anti-Bribery Year-in-Review: 2020 Developments and Predictions for 2021
School District Immune from FCA Claims, but Employees Might be Liable; United States District Court for the Northern District of California No. 16-cv-06994-PJH, U.S. ex rel. Steven Fallon et al. v. Bell Transit Corp., et al.
Omnicare and CVS’s “Novel” Argument Fails to Defeat FCA Claims
DOJ Continues to Combat COVID-19 Fraud with “Historic” Levels of Enforcement
Keep reading


